Back
Belite Bio, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45
BLTE
Belite Bio, Inc.
Last Price:
$173.40
Seasonality Move:
-11.58%
7 Day Trial
ALL ACCESS PASS
$
7
Belite Bio, Inc. Stock Forecast
-
Over the next 52 weeks, Belite Bio, Inc. has on average historically risen by 86.8% based on the past 3 years of stock performance.
-
Belite Bio, Inc. has risen higher in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is Belite Bio, Inc. Stock Undervalued?The current Belite Bio, Inc. [BLTE] share price is $172.57. The Score for BLTE is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
BLTE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Belite Bio, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Belite Bio, Inc. has on average historically risen by 86.8% based on the past 3 years of stock performance.
Belite Bio, Inc. Stock Rating
Sell
45
Belite Bio, Inc. (BLTE)
is a Sell
Is Belite Bio, Inc. overpriced?
-
Belite Bio, Inc. has risen higher in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Belite Bio, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
belitebio.com
52-Week Data
52-Week High:
200.00
52-Week Low:
49.00
Prediction Charts
Market Cap:
6.5B
Price in USD:
172.57
Volume:
129.9K
Beta:
-1.34
Technical Analysis
SMA50:
169.23
SMA100:
144.00
SMA200:
104.68
52-Wk Change:
185.9%
Stock Predictions
-
Is Belite Bio, Inc. stock public?Yes, Belite Bio, Inc. is a publicly traded company.
-
What is the Belite Bio, Inc. stock quote today?The Belite Bio, Inc. stock price is 172.57 USD today.
-
How to buy Belite Bio, Inc. stock online?You can buy Belite Bio, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-13 | 177.22 | 175.26 | 177.22 | 171.35 |
| Feb-17 | 176.61 | 175.84 | 179.78 | 171.78 |
| Feb-18 | 174.90 | 173.91 | 180.28 | 171.00 |
| Feb-19 | 176.46 | 179.77 | 180.45 | 172.80 |
| Feb-20 | 180.47 | 180.95 | 181.06 | 176.48 |
| Feb-23 | 180.95 | 189.26 | 191.50 | 180.95 |
| Feb-24 | 188.00 | 186.15 | 190.80 | 184.85 |
| Feb-25 | 187.02 | 188.04 | 190.36 | 183.90 |
| Feb-26 | 187.75 | 188.55 | 189.80 | 183.91 |
| Feb-27 | 186.31 | 190.30 | 192.28 | 186.31 |
| Mar-2 | 188.75 | 177.58 | 188.75 | 173.32 |
| Mar-3 | 177.60 | 167.88 | 180.75 | 167.59 |
| Mar-4 | 170.06 | 177.79 | 179.11 | 167.90 |
| Mar-5 | 177.79 | 172.57 | 178.93 | 172.57 |
Belite Bio, Inc. Earnings
Belite Bio, Inc. Earnings Report: Per Share Belite Bio, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Belite Bio, Inc. Forecast Revenue Growth
Belite Bio, Inc. Stock Analysis: Historical quarterly revenues per share for Belite Bio, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.19 per share, an increase next quarter of $0.36 per share, an increase this year of $0.09 per share, and an increase next year of $0.78 per share.
* Belite Bio, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.